Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.
Shuttle Pharmaceuticals has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Shuttle Pharmaceuticals is headquartered in Rockville, United States.
Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.
Shuttle Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shuttle Pharmaceuticals — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/shuttle-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2026). Shuttle Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/shuttle-pharmaceuticals
{{cite web |title=Shuttle Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/shuttle-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated